Thomas J Schnitzer

Grants

Grants per year 2002 2004 2005 2006 2007 2008 2010 2015 2016 2028

• 20 Active
• 118 Finished

Grants per year

Search results

• Finished

  Prot #TGC12301: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 3 Study to Determine the Efficacy of TG-C in Subjects with Kellgren and Lawrence Grade 2 or 3 Osteoarthritis of the Knee

  Schnitzer, T. J. (PD/PI)

  Medpace Clinical Research LLC, Kolon TissueGene, Inc.

  4/19/24 → 4/19/25

  Project: Research project

• Prot #PARA_OA_002: A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared with Placebo in Participants with Knee Osteoarthritis Pain

  Schnitzer, T. J. (PD/PI)

  Premier Research International, LLC, Paradigm Biopharmaceuticals (USA) Inc.

  1/18/22 → 1/18/25

  Project: Research project

• Prot #TF-X0002-31: A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects with Osteoarthritis of t

  Schnitzer, T. J. (PD/PI)

  Premier Research International, LLC, Techfields, Inc.

  10/15/21 → 10/15/24

  Project: Research project

• Transcranial Magnetic Stimulation to Enhance Cortical-Hippocampal Functional Connectivity as a Novel Means for Relieving Chronic OA Pain

  Apkarian, A. (PD/PI), Schnitzer, T. J. (Co-PD/PI) & Voss, J. L. (Co-Investigator)

  Pfizer Inc.

  5/24/21 → 5/31/23

  Project: Research project

• Prot #Cingal 19-01: A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee

  Schnitzer, T. J. (PD/PI)

  SynteractHCR, Inc., Anika Therapeutics, Inc.

  9/11/20 → 9/11/23

  Project: Research project

• Data Center for Acute to Chronic Pain Biosignatures

  Apkarian, A. (PD/PI), Apkarian, A. (PD/PI), Griffith, J. W. (Co-Investigator), Griffith, J. W. (Co-Investigator), Schnitzer, T. J. (Co-Investigator) & Schnitzer, T. J. (Co-Investigator)

  Johns Hopkins University, National Institute on Drug Abuse

  8/1/20 → 7/31/23

  Project: Research project

  • Clinical Data 100%
  • Acute to Chronic 100%
  • Biosignatures 100%
  • Chronic Pain 100%
  • Griffith 50%

• Prot #R475-OA-1816: Study to Evaluate Arthroplasty Specimens in the Phase 3 Fasinumab Program for Osteoarthritis of the Knee and Hip

  Schnitzer, T. J. (PD/PI)

  ICON Clinical Research Limited, Regeneron Pharmaceuticals, Inc.

  5/14/19 → 5/14/22

  Project: Research project

• Prot #R475-OA-1758: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients with Pain due to Osteoarthritis of the Hip or Knee

  Schnitzer, T. J. (PD/PI)

  inVentiv Health Clinical, Regeneron Pharmaceuticals, Inc.

  2/21/19 → 2/21/24

  Project: Research project

• Prot #FX006-2018-015: A Randomized, Double-Blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Patients with Hip Osteoarthritis

  Schnitzer, T. J. (PD/PI)

  Flexion Therapeutics, Inc.

  2/6/19 → 2/6/22

  Project: Research project

• Main Project

  Apkarian, A. (PD/PI), Griffith, J. W. (Co-Investigator), Kahnt, T. (Co-Investigator), Manning, D. W. (Co-Investigator), Parrish, T. B. (Co-Investigator) & Schnitzer, T. J. (Co-Investigator)

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  2/1/19 → 12/31/24

  Project: Research project

• (PRESPEND) Prot #R475-OA-1815: Study to Evaluate Synovial Fluid in the Phase 3 Fasinumab Program for Osteoarthritis of the Knee and Hip

  Schnitzer, T. J. (PD/PI)

  ICON Clinical Research Limited, Regeneron Pharmaceuticals, Inc.

  1/24/19 → 1/24/20

  Project: Research project

• Prot #CL2-201086-002/GLPG1972-CL-201: Efficacy and safety of 3 doses of S201086/GLPG1972 administered orally once daily in patients with knee osteoarthritis. A 52-week international, multi-regional, multi-center, randomized, double-blind, placebo-controll

  Schnitzer, T. J. (PD/PI)

  Medpace Clinical Research LLC, Galapagos NV

  12/4/18 → 12/4/21

  Project: Research project

• Prot# BA058-05-019: A Randomized, Double-blind, Placebo-controlled, Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of Abaloparatide-SC for the Treatment of Men with Osteoporosis

  Schnitzer, T. J. (PD/PI)

  ICON Clinical Research, LLC, Radius Health, Inc.

  6/13/18 → 6/13/25

  Project: Research project

• Prot #R475-OA-1611: A Phase 3 Randomized, Double-Blind, Multi-Dose, Placebo and Naproxen-Controlled Study to Evaluate the Efficacy and Safety of Fasinumab in Patients with Pain Due to Osteoarthritis of the Knee or Hip

  Schnitzer, T. J. (PD/PI)

  ICON Clinical Research Limited, Regeneron Pharmaceuticals, Inc.

  10/25/17 → 11/25/23

  Project: Research project

• D-Cycloserine for the Treatment of Chronic, Refractory Low Back Pain

  Schnitzer, T. J. (PD/PI), Apkarian, A. (Co-Investigator) & Griffith, J. W. (Co-Investigator)

  U.S. Army Medical Research and Materiel Command

  9/30/17 → 9/29/24

  Project: Research project

• Prot #KF7013-03: Open-label safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS)

  Schnitzer, T. J. (PD/PI)

  Worldwide Clinical Trials, Inc., Grunenthal GmbH

  1/17/17 → 1/17/22

  Project: Research project

• Increasing Bone Mass and Bone Strength in Individuals with Chronic Spinal Cord Injury: Maximizing Response to Therapy

  Schnitzer, T. J. (PD/PI)

  U.S. Army Medical Research and Materiel Command

  9/30/16 → 3/29/19

  Project: Research project

  • Bone Strength 100%
  • Bone Mass 100%
  • Chronic Spinal Cord Injury 100%
  • Response to Therapy 100%
  • Spinal Cord Injury 100%

• Prot #A4091056: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Analgesic Efficacy and Safety of a Dose Titration Regimen for the Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee

  Schnitzer, T. J. (PD/PI)

  INC Research, LLC, Pfizer Inc.

  8/2/16 → 8/2/19

  Project: Research project

• Cortico-striatal plasticity in the transition to chronic pain

  Apkarian, A. (PD/PI), Griffith, J. W. (Co-Investigator), Martina, M. (Co-Investigator), Parrish, T. B. (Co-Investigator), Procissi, D. (Co-Investigator), Schnitzer, T. J. (Co-Investigator) & Surmeier Jr, D. J. (Co-Investigator)

  National Institute of Dental and Craniofacial Research

  7/1/16 → 12/31/18

  Project: Research project

• Brain mechanisms for clinical placebo in chronic pain

  Apkarian, A. (PD/PI), Cella, D. (Co-Investigator), Gershon, R. (Co-Investigator), Parrish, T. B. (Co-Investigator), Schnitzer, T. J. (Co-Investigator) & Griffith, J. W. (Other)

  National Center for Complementary and Integrative Health

  6/1/16 → 5/31/18

  Project: Research project

• Prot #AXS02-K301: COAST-1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study- A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Kn

  Schnitzer, T. J. (PD/PI)

  Axsome Therapeutics, Inc.

  3/15/16 → 11/30/20

  Project: Research project

• Prot #AXS02-301: CREATE-1 Study: CRPS Treatment Evaluation 1 Study: A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Complex Regional

  Schnitzer, T. J. (PD/PI)

  Axsome Therapeutics, Inc.

  3/10/16 → 3/10/19

  Project: Research project

• Prot #R475-PN-1524: A Randomized, Double-blind, Multi-dose, Placebo-controlled Phase 2/3 Study to Evaluate the Efficacy and Safety of Fasinumab in Patients with Moderate to Severe Chronic Low Back Pain

  Schnitzer, T. J. (PD/PI)

  ICON Clinical Research, LLC, Regeneron Pharmaceuticals, Inc.

  3/10/16 → 4/15/21

  Project: Research project

• Functional Performance Evaluation of the Northwestern University Flexible Sub-Ischial Vacuum (NU-FlexSIV) Socket for Persons with Transfemoral Amputation

  Fatone, S. (PD/PI), Schnitzer, T. J. (Co-Investigator) & Caldwell, R. J. (Other)

  U.S. Army Medical Research and Materiel Command

  9/30/15 → 9/29/20

  Project: Research project

  • Ischium 100%
  • Socket 100%
  • Northwestern University 100%
  • Functional Assessment 100%
  • Transfemoral Amputation 100%

• Prot #A4091064: A Phase 3, Multicenter, Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement

  Schnitzer, T. J. (PD/PI)

  inVentiv Health Clinical, Pfizer Inc.

  9/11/15 → 9/11/19

  Project: Research project